Phase I trial of concurrent erlotinib, celecoxib, and reirradiation for recurrent head and neck cancer

被引：2
|
作者：
Kao, J. [1 ]
Packer, S. H. [1 ]
Teng, M. [1 ]
Gupta, V. [1 ]
Misiukiewicz, K. [1 ]
Genden, E. M. [1 ]
机构：
[1] Mt Sinai Sch Med, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.5561
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5561
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Prior Chemoradiotherapy Adversely Impacts Outcomes of Recurrent and Second Primary Head and Neck Cancer Treated With Concurrent Chemotherapy and Reirradiation
    Choe, Kevin S.
    Haraf, Daniel J.
    Solanki, Abhishek
    Cohen, Ezra E. W.
    Seiwert, Tanguy Y.
    Stenson, Kerstin M.
    Blair, Elizabeth A.
    Portugal, Louis
    Villaflor, Victoria M.
    Witt, Mary Ellyn
    Vokes, Everett E.
    Salama, Joseph K.
    CANCER, 2011, 117 (20) : 4671 - 4678
  • [42] A phase II prospective trial of SBRT reirradiation for recurrent or 2nd primary head & neck cancers
    Fouda, Sally S.
    Shouman, Tarek H.
    Hassouna, Ashraf H.
    Amin, Ayman A.
    Hassan, Maha
    Abdelgeleel, Shaimaa
    Ashour, May G.
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S1180 - S1181
  • [43] Reirradiation in recurrence of head and neck cancer
    Loessl, K.
    Beer, K. T.
    Aebersold, D.
    Greiner, R. H.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2006, 182 : 174 - 174
  • [44] Efficacy of reirradiation in head and neck cancer
    Diaz Gomez, L.
    Gonzalez Calvo, E.
    Gutierrez Bayard, L.
    Villanego Beltran, I.
    Munive Alvarez, E.
    Diaz Diaz, V.
    De Ingunza Baron, L.
    Salas Buzon, M. C.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S764 - S764
  • [45] Phase I study of gefitinib plus celecoxib in recurrent or metastatic squamous cell carcinoma of the head and neck
    Wirth, LJ
    Haddad, RI
    Lindeman, NI
    Zhao, XJ
    Lee, JC
    Joshi, VA
    Norris, CM
    Posner, MR
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (28) : 6976 - 6981
  • [46] A phase I study of erlotinib and bevacizumab for recurrent or metastatic squamous cell carcinoma of the head and neck (HNC).
    Vokes, EE
    Cohen, EEW
    Mauer, AM
    Karrison, TG
    Wong, SJ
    Skoog-Sluman, LJ
    Kozloff, MF
    Dancey, J
    Dekker, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 501S - 501S
  • [47] Reirradiation in head and neck recurrent cancer or second primary. Our experience
    Gutierrez Bayard, Lucia
    Rodriguez Sanchez, Raquel
    Munoz Higueras, Cristina
    ORAL ONCOLOGY, 2021, 118
  • [48] Reirradiation: a potentially curative approach to locally or regionally recurrent head and neck cancer
    Garofalo, MC
    Haraf, DJ
    CURRENT OPINION IN ONCOLOGY, 2002, 14 (03) : 330 - 333
  • [49] Reirradiation of recurrent head and neck cancers with curative intent
    Chmura, SJ
    Milano, MT
    Haraf, DJ
    SEMINARS IN ONCOLOGY, 2004, 31 (06) : 816 - 821
  • [50] A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFerade™ Biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiation
    Seiwert, T. Y.
    Darga, T.
    Haraf, D.
    Blair, E. A.
    Stenson, K.
    Cohen, E. E. W.
    Salama, J. K.
    Villaflor, V.
    Witt, M. E.
    Lingen, M. W.
    Weichselbaum, R. R.
    Vokes, E. E.
    ANNALS OF ONCOLOGY, 2013, 24 (03) : 769 - 776
12345